Evidence Hub

Assessing the non-inferiority of a 10-day compared with a 14-day vonoprazan–amoxicillin dual therapy regimen for H. pylori eradication: a systematic review and meta-analysis

Azzam Zrineh, Rami Akwan, Muhammad M. Elsharkawy, M. R. Mahmoud, Hadeel Jameel Ayesh, Mohammad Shehata, Hamza Karmi, Elsayed S Moubarak

BMC Infectious Diseases, 2026

2,587 participants · 1 citation

Abstract

BACKGROUND: Helicobacter pylori infection affects approximately 50% of the global population and remains a major cause of peptic ulcer disease and gastric cancer. Vonoprazan, a novel potassium-competitive acid blocker, has emerged as a promising alternative to proton pump inhibitors in H. pylori eradication regimens. Vonoprazan-amoxicillin dual therapy offers a simplified treatment approach with potentially high eradication rates. However, the optimal treatment duration remains uncertain, with important implications for patient adherence, adverse events, and antimicrobial resistance. This systematic review and meta-analysis aimed to evaluate whether 10-day vonoprazan-amoxicillin dual therapy is non-inferior to the standard 14-day regimen for H. pylori eradication in adults. METHODS: We conducted a systematic search of major medical databases for randomized controlled trials published up to September 27, 2025. The primary outcome was H. pylori eradication rate, with secondary outcomes including adverse events and treatment compliance. Risk differences with 95% confidence intervals were calculated for primary outcomes, and risk ratios with 95% confidence intervals were calculated for secondary outcomes, using a random-effects model. Quality assessment was performed using the Cochrane Risk of Bias 2.0 tool. RESULTS: Seven randomized controlled trials were identified, of which six trials were included in the quantitative analysis. In the intention-to-treat population (n =…

How strong is the evidence?

Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 2,587 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free